1. INSIDE INDUSTRY.
- Subjects
BIOTECHNOLOGY ,DRUG development ,LOW density lipoproteins ,DRUG approval ,MASS spectrometers ,INDIVIDUALIZED medicine ,MAMMOGRAMS ,BUSINESS partnerships - Abstract
First of Its Kind Treatment - Repatha® (evolocumab) - Available to Address Unmet Needs in Patients with Uncontrolled LDL Cholesterol in Singapore. Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer. Bristol-Myers Squibb's Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Approval from Singapore's Health Sciences Authority in Unresectable or Metastatic Melanoma [1]. National Supercomputing Centre Singapore and Global Gene Corp Sign a Strategic Collaboration in Support of Singapore's Precision Medicine Initiative. Parkway Pantai Introduces New 3-D Mammography Technology in Singapore Developed by GE Healthcare with More Patient Comfort in Mind. Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore. Siemens Launches First Fully Integrated Digitalization Hub in Singapore. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF